Mirati Therapeutics Reports Promising Data from Clinical Trials

Mirati Therapeutics Reports Promising Data from Clinical Trials

Mirati Therapeutics reported late Thursday promising data from two ongoing clinical programs, including the Phase 1b and Phase 2 trials of glesatinib, a spectrum selective kinase inhibitor for the treatment of non-small cell lung cancer (NSCLC) patients with genetic alterations of MET, and the Phase 1b trial of sitravatinib, a receptor tyrosine kinase inhibitor for the treatment of genetically-selected NSCLC and other solid tumors. Shares were down 6% in the […]

Read More ˃
Interface to Close Most FLOR Stores in Restructuring Plan

Interface to Close Most FLOR Stores in Restructuring Plan

Interface will close the majority of its FLOR retail stores between January and April and take a charge of a total of about $25 to $27 million in a restructuring plan. The job reductions include about 70 FLOR workers and “a number of other employees in the commercial business in the Americas and Europe regions,” the company said. In Q4 2016, the company expects to incur a pre-tax restructuring and […]

Read More ˃
Sizing Up Semgroup Corporation (NYSE:SEMG) Shares as Analysts Weigh In

Sizing Up Semgroup Corporation (NYSE:SEMG) Shares as Analysts Weigh In

Analysts on the Street predict that Semgroup Corporation (NYSE:SEMG) is going to report earnings of $0.17 per share.  This article will dive a bit deeper into how analysts make that prediction, and also look into how investors can use those predictions to make the decision to “buy” or “sell”.   According to Zacks the actual earnings for Semgroup Corporation (NYSE:SEMG) will be released on or around 2017-02-23 .    Before we […]

Read More ˃
Sell-Side Sights Are Set on Shell Midstream Partners, L.P. (NYSE:SHLX) and Where the Shares Are Headed

Sell-Side Sights Are Set on Shell Midstream Partners, L.P. (NYSE:SHLX) and Where the Shares Are Headed

Earnings is fast approaching and sell-side firms around the globe are crunching numbers to help investors make sound investment decisions.  Analysts are forecasting that Shell Midstream Partners, L.P. (NYSE:SHLX) is going to report earnings of $0.33 per share.  The actual numbers will be released when the company reports earnings on or around 2017-02-22.  Before we delve into the numbers, let’s look at the surprise factor.  Investors want to know right off […]

Read More ˃
Price Target Analysis On Shares of Esterline Technologies Corporation (NYSE:ESL)

Price Target Analysis On Shares of Esterline Technologies Corporation (NYSE:ESL)

Earnings is around the corner and the analysts are predicting that Esterline Technologies Corporation (NYSE:ESL) is expected to report earnings of $0.45 per share.  Will the analysts hit the mark?  Investors will know for sure when the company releases their earnings report on or around 2017-02-02.  Before we delve into the numbers, let’s look at the surprise factor.  Investors want to know right off the bat about the surprise factor. […]

Read More ˃
How Favorably Do Analysts Perceive Ingersoll-Rand plc (Ireland) (NYSE:IR) Shares Ahead of Earnings?

How Favorably Do Analysts Perceive Ingersoll-Rand plc (Ireland) (NYSE:IR) Shares Ahead of Earnings?

Ingersoll-Rand plc (Ireland) (NYSE:IR) is expected to report earnings of $0.92 per share when the firm issues their next quarterly results.  The firm will most likely release their report on or around 2017-02-14 . This is based on the most recent information offered by Zacks.  Before we delve into the numbers, let’s look at the surprise factor.  Investors want to know right off the bat about the surprise factor.  This […]

Read More ˃